Decompensated Cirrhosis
📧 Sign up to get email alerts when something new happens for Decompensated Cirrhosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Effect of Albumin Infusion on Oxidative Albumin Modification, Albumin Binding Capacity and Plasma Thiol Status
A completed clinical trial evaluated the effect of albumin infusion on oxidative modification of albumin, albumin binding capacity, and plas…
-
CLINICAL_TRIALS other · 2025-02-17Clinical Trial Update: Replicor Compassionate Access Program
Replicor's compassionate access program for hepatitis B and hepatitis D, along with related liver diseases, is no longer available.
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: LEOPARD Prospective Validation Cohort 1
This clinical trial update describes the LEOPARD prospective validation cohort 1 by Assistance Publique - Hôpitaux de Paris and lists condit…
-
CLINICAL_TRIALS research · 2024-10-18Clinical Trial Update: Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2) [Phase 2]
Phase 2 clinical trial evaluating human umbilical cord-derived mesenchymal stem cells for decompensated cirrhosis is currently recruiting at…
-
CLINICAL_TRIALS research · 2024-09-27Clinical Trial Update: Trial Comparing Conventional Antibiotic Strategies Versus Regimens Guided by Epidemiological Surveillance in Infected Patients With Cirrhosis (SURVIC_STUDY) [Phase 4]
A Phase 4 trial comparing conventional antibiotic strategies versus regimens guided by epidemiological surveillance in patients with decompe…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-08-01Clinical Trial Update: Fecal Microbiome Transplantation in Cirrhosis: Trial in Patients With Decompensated Cirrhosis [Phase 3]
A Phase 3 clinical trial evaluating fecal microbiome transplantation for decompensated cirrhosis is listed as not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: A Study for Evaluation of BIV201 to Reduce Ascites and Complications in Patients With Cirrhosis and Refractory Ascites [Phase 2]
Phase 2 study evaluating BIV201 to reduce ascites and complications in patients with cirrhosis and refractory ascites has been terminated.
-
CLINICAL_TRIALS trial_result · 2023-01-06Clinical Trial Update: Primary Prophylaxis for Spontaneous Bacterial Peritonitis [Phase 2, Phase 3]
A Phase 2/3 clinical trial investigating primary prophylaxis for spontaneous bacterial peritonitis in decompensated cirrhosis has been termi…
-
CLINICAL_TRIALS trial_result · 2021-11-16Clinical Trial Update: Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis [Phase 2]
Phase 2 clinical trial evaluating human umbilical cord-derived mesenchymal stem cells for decompensated cirrhosis.
-
CLINICAL_TRIALS trial_result · 2021-06-07Clinical Trial Update: Avatrombopag in Patients With End-stage Liver Disease and Thrombocytopenia [Phase 4]
Phase 4 trial investigating avatrombopag for thrombocytopenia in patients with liver failure and related conditions, status currently unknow…
-
CLINICAL_TRIALS trial_result · 2020-12-16Clinical Trial Update: Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-17
A companion protocol update for a methacetin breath test in the Meridian Bioscience study (NCT03462576) related to decompensated cirrhosis; …
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Injectable Collagen Scaffold™ Combined With HUC-MSCs Transplantation for Patients With Decompensated Cirrhosis [Phase 1, Phase 2]
Phase 1/2 trial investigating Injectable Collagen Scaffold™ combined with human umbilical cord mesenchymal stem cells for decompensated cirr…
-
CLINICAL_TRIALS research · 2019-07-19Clinical Trial Update: GCSF Therapy in Decompensated Cirrhosis - A Double Blinded RCT [Phase 2, Phase 3]
Clinical trial update for GCSF therapy in decompensated cirrhosis across Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2019-03-19Clinical Trial Update: Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis [Phase 2]
Phase 2 clinical trial update for emricasan, a caspase inhibitor, in subjects with decompensated cirrhosis due to non-alcoholic steatohepati…
-
CLINICAL_TRIALS trial_result · 2019-01-17Clinical Trial Update: Early TIPS With Polytetrafluoroethylene (PTFE) Covered Stents for Acute Variceal Bleeding in Patients With Advanced Cirrhosis [NA]
Clinical trial update on early transjugular intrahepatic portosystemic shunt (TIPS) using PTFE-covered stents for acute variceal bleeding in…
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis [Phase 3]
Phase 3 trial evaluating the safety and efficacy of ombitasvir/paritaprevir/ritonavir with dasabuvir and ribavirin in adults with genotype 1…
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: To Study The Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction in Decompensated Cirrhotics Undergoing Less Than 5 Litres Of Ascitic Fluid Tap With Or Without Albumin Infusion. [NA]
This ClinicalTrials.gov study evaluated the incidence and outcomes of paracentesis-induced circulatory dysfunction in patients with decompen…
-
CLINICAL_TRIALS research · 2017-05-19Clinical Trial Update: Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Prevention of Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis [NA]
Clinical trial NCT01326949 evaluating Transjugular Intrahepatic Portosystemic Shunt (TIPS) for prevention of variceal rebleeding in patients…
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: Fecal Microbiota Transplantation for Decompensated Cirrhosis [Phase 1, Phase 2]
This document reports an ongoing Phase 1/2 clinical trial evaluating fecal microbiota transplantation for decompensated cirrhosis; the curre…
-
CLINICAL_TRIALS trial_result · 2016-11-22Clinical Trial Update: A Trial to Study the Influence of Growth Factors on Bone Marrow and Hepatic Regeneration in Patients With Decompensated Cirrhosis. [NA]
A completed clinical trial studying the influence of growth factors on bone marrow and hepatic regeneration in patients with decompensated c…
-
CLINICAL_TRIALS trial_result · 2016-10-18Clinical Trial Update: To Assess the Efficacy of Granulocyte Colony Stimulating Factor Versus Standard Medical Therapy in Patients of Decompensated Cirrhosis [Phase 3]
A Phase 3 trial evaluating granulocyte colony-stimulating factor versus standard medical therapy in decompensated cirrhosis has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation [Phase 2]
Phase 2 trial evaluating sofosbuvir and ribavirin in adults with chronic hepatitis C and cirrhosis, including patients with portal hypertens…
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: TIPS With 8- OR 10-mm Covered Stent for Preventing Variceal Rebleeding [NA]
A completed clinical trial evaluated using 8- or 10-mm covered stents for transjugular intrahepatic portosystemic shunt (TIPS) to prevent va…
-
CLINICAL_TRIALS trial_result · 2015-08-03Clinical Trial Update: Biomarkers for the Prognosis of Decompensated Alcoholic Liver Disease
A completed University of Nottingham clinical trial investigated biomarkers to predict prognosis in decompensated alcoholic liver disease.
-
CLINICAL_TRIALS trial_result · 2014-02-28Clinical Trial Update: Rifaximin Predicts the Complications of Decompensated Cirrhosis [Phase 4]
Phase 4 trial update evaluating rifaximin for predicting complications in patients with decompensated cirrhosis.